Showing results (2371-2380 of 6,517) with videos related to
Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|April 27, 2000
Initial steps in lymph node metastasis formation in an experimental system: possible involvement of recognition by macrophage C-type lectinsS Ichii, Y Imai, T IrimuraCancer Immunology, Immunotherapy : CII|April 27, 2000
B7-2 expression on tumor cells is important for the acquisition of cytotoxic T lymphocyte activity by spleen cells from low-dose-melphalan-treated MOPC-315 tumor bearers via a mechanism that requires either B7-1 or B7-2 expression on host antigen-presenting cellsD K Sojka, R N La Motte, M B MokyrCancer Immunology, Immunotherapy : CII|April 27, 2000
Phase I trial of interleukin-2 and high-dose arginine butyrate in metastatic colorectal cancerJ Y Douillard, J Bennouna, F Vavasseur, et al.Cancer Immunology, Immunotherapy : CII|August 15, 2000
Pharmacokinetics and biodistribution of a light-chain-shuffled CC49 single-chain Fv antibody constructG Pavlinkova, D Colcher, B J Booth, et al.Cancer Immunology, Immunotherapy : CII|August 18, 2000
Modulation of interleukin-12 synthesis by DNA lacking the CpG motif and present in a mycobacterial cell wall complexM C Filion, B Filion, S Reader, et al.Cancer Immunology, Immunotherapy : CII|July 6, 2000
Cancer vaccines: single-epitope anti-idiotype vaccine versus multiple-epitope antigen vaccineH Maruyama, J Zaloudik, W Li, et al.Cancer Immunology, Immunotherapy : CII|July 6, 2000
Counterpoint. Cancer vaccines: single-epitope anti-idiotype vaccine versus multiple-epitope antigen vaccineM Bhattachary-Chatterjee, R Nath Baral, S K Chatterjee, et al.Cancer Immunology, Immunotherapy : CII|July 6, 2000
Intracellular cytokine profile of T cells from children with acute lymphoblastic leukemiaX L Zhang, Y Komada, J Chipeta, et al.Cancer Immunology, Immunotherapy : CII|June 23, 2001
Lymphocyte subsets and viral load in patients with HIV-associated non-Hodgkin's lymphoma treated with anti-CD20 monoclonal antibody and chemotherapyP De Paoli, E Vaccher, R Tedeschi, et al.Cancer Immunology, Immunotherapy : CII|June 23, 2001
Tumor cell killing by in vitro affinity-matured recombinant human monoclonal antibodiesG Huls, D Gestel, J van der Linden, et al.Pageof 652